189 related articles for article (PubMed ID: 20375176)
1. A single coxsackievirus B2 capsid residue controls cytolysis and apoptosis in rhabdomyosarcoma cells.
Gullberg M; Tolf C; Jonsson N; Polacek C; Precechtelova J; Badurova M; Sojka M; Mohlin C; Israelsson S; Johansson K; Bopegamage S; Hafenstein S; Lindberg AM
J Virol; 2010 Jun; 84(12):5868-79. PubMed ID: 20375176
[TBL] [Abstract][Full Text] [Related]
2. Cytolytic replication of coxsackievirus B2 in CAR-deficient rhabdomyosarcoma cells.
Polacek C; Ekström JO; Lundgren A; Lindberg AM
Virus Res; 2005 Nov; 113(2):107-15. PubMed ID: 15964091
[TBL] [Abstract][Full Text] [Related]
3. Genomic and phylogenetic characterization of coxsackievirus B2 prototype strain Ohio-1.
Polacek C; Lundgren A; Andersson A; Lindberg AM
Virus Res; 1999 Feb; 59(2):229-38. PubMed ID: 10082394
[TBL] [Abstract][Full Text] [Related]
4. Symmetry-related clustering of positive charges is a common mechanism for heparan sulfate binding in enteroviruses.
McLeish NJ; Williams ÇH; Kaloudas D; Roivainen MM; Stanway G
J Virol; 2012 Oct; 86(20):11163-70. PubMed ID: 22855495
[TBL] [Abstract][Full Text] [Related]
5. Mouse adaptation of a sub-genogroup B5 strain of human enterovirus 71 is associated with a novel lysine to glutamic acid substitution at position 244 in protein VP1.
Zaini Z; Phuektes P; McMinn P
Virus Res; 2012 Jul; 167(1):86-96. PubMed ID: 22575826
[TBL] [Abstract][Full Text] [Related]
6. Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3.
Lindberg AM; Crowell RL; Zell R; Kandolf R; Pettersson U
Virus Res; 1992 Jul; 24(2):187-96. PubMed ID: 1326828
[TBL] [Abstract][Full Text] [Related]
7. Interactions between multiple genetic determinants in the 5' UTR and VP1 capsid control pathogenesis of chronic post-viral myopathy caused by coxsackievirus B1.
Sandager MM; Nugent JL; Schulz WL; Messner RP; Tam PE
Virology; 2008 Mar; 372(1):35-47. PubMed ID: 18029287
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain.
Girn J; Kavoosi M; Chantler J
J Gen Virol; 2002 Feb; 83(Pt 2):351-358. PubMed ID: 11807228
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
Schmidtke M; Hammerschmidt E; Schüler S; Zell R; Birch-Hirschfeld E; Makarov VA; Riabova OB; Wutzler P
J Antimicrob Chemother; 2005 Oct; 56(4):648-56. PubMed ID: 16150864
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of coxsackievirus B2 in mice: characterization of clinical isolates of the coxsackievirus B2 from patients with myocarditis and aseptic meningitis in Korea.
Hong J; Kang B; Yeo S; Jee Y; Park JH
J Vet Sci; 2017 Dec; 18(4):457-464. PubMed ID: 28384999
[TBL] [Abstract][Full Text] [Related]
11. The Transcriptome of Rhabdomyosarcoma Cells Infected with Cytolytic and Non-Cytolytic Variants of Coxsackievirus B2 Ohio-1.
Sävneby A; Luthman J; Nordenskjöld F; Andersson B; Lindberg AM
PLoS One; 2016; 11(10):e0164548. PubMed ID: 27760161
[TBL] [Abstract][Full Text] [Related]
12. Two clusters of mutations map distinct receptor-binding sites of echovirus 11 for the decay-accelerating factor (CD55) and for canyon-binding receptors.
Rezaikin AV; Novoselov AV; Sergeev AG; Fadeyev FA; Lebedev SV
Virus Res; 2009 Oct; 145(1):74-9. PubMed ID: 19540285
[TBL] [Abstract][Full Text] [Related]
13. MOPS and coxsackievirus B3 stability.
Carson SD; Hafenstein S; Lee H
Virology; 2017 Jan; 501():183-187. PubMed ID: 27940223
[TBL] [Abstract][Full Text] [Related]
14. 5' terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart.
Chapman NM; Kim KS; Drescher KM; Oka K; Tracy S
Virology; 2008 Jun; 375(2):480-91. PubMed ID: 18378272
[TBL] [Abstract][Full Text] [Related]
15. Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells.
Reagan KJ; Goldberg B; Crowell RL
J Virol; 1984 Mar; 49(3):635-40. PubMed ID: 6321753
[TBL] [Abstract][Full Text] [Related]
16. Slow Infection due to Lowering the Amount of Intact versus Empty Particles Is a Characteristic Feature of Coxsackievirus B5 Dictated by the Structural Proteins.
Turkki P; Laajala M; Stark M; Vandesande H; Sallinen-Dal Maso H; Shroff S; Sävneby A; Galitska G; Lindberg AM; Marjomäki V
J Virol; 2019 Oct; 93(20):. PubMed ID: 31375587
[TBL] [Abstract][Full Text] [Related]
17. Human rhabdomyosarcoma cells for rapid detection of enteroviruses by shell-vial assay.
Pérez-Ruiz M; Navarro-Marí JM; Palacios Del Valle E; Rosa-Fraile M
J Med Microbiol; 2003 Sep; 52(Pt 9):789-791. PubMed ID: 12909656
[TBL] [Abstract][Full Text] [Related]
18. The apoptotic capability of coxsackievirus B3 is influenced by the efficient interaction between the capsid protein VP2 and the proapoptotic host protein Siva.
Henke A; Nestler M; Strunze S; Saluz HP; Hortschansky P; Menzel B; Martin U; Zell R; Stelzner A; Munder T
Virology; 2001 Oct; 289(1):15-22. PubMed ID: 11601913
[TBL] [Abstract][Full Text] [Related]
19. Single-Point Mutations within the Coxsackie B Virus Receptor-Binding Site Promote Resistance against Soluble Virus Receptor Traps.
Pinkert S; Kopp A; Brückner V; Fechner H; Beling A
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669334
[TBL] [Abstract][Full Text] [Related]
20. [Pentapeptides prevent enterovirus 71 proliferation in rhabdomyosarcoma cells and mice].
Yang Z; Tian B
Yao Xue Xue Bao; 2014 Apr; 49(4):457-62. PubMed ID: 24974461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
